The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU

Phosphate Levels of COVID-19 Patients and Mortality

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04800770

Enrollment

160

Registered

2021-03-16

Start date

2021-03-03

Completion date

2021-07-31

Last updated

2021-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Mortality, Phosphate Deficiency

Keywords

COVID19, phosphate deficiency, 4C mortality score

Brief summary

The investigators aimed to investigate the relationship between phosphate level and mortality using the 4C Mortality Score in COVID-19 patients who were followed up in the intensive care unit.

Interventions

DIAGNOSTIC_TEST4C mortality score

4C mortality score and phosphate levels

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Participants hospitalized in the intensive care unit diagnosed with COVID-19 will incluse in the study

Exclusion criteria

* there is no

Design outcomes

Primary

Measure	Time frame	Description
4C mortality score	6 months	4C Mortality Scores of the patients will be calculated, according to age, gender, number of comorbidities, respiratory rate, SpO2, GCS, urea, and CRP parameters
serum phosphate levels	6 months	mg/dl
mortality	28 days	mortality percentage of patients in 28 days

Countries

Turkey (Türkiye)

Contacts

Primary Contactbetül aytaç, MD

drbguven@hotmail.com+905073578351

Backup Contactismail aytaç, MD

aytacismail1972@gmail.com+905056340369

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026